FSGS

Clinical trials for FSGS explained in plain language.

Never miss a new study

Get alerted when new FSGS trials appear

Sign up with your email to follow new studies for FSGS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1

New drug trial aims to protect kidneys from scarring disease

Disease control Not yet recruiting

This research study is testing whether regular injections of an investigational drug called APL2 can help control focal segmental glomerulosclerosis (FSGS), a serious kidney disease that causes scarring. The study will involve about 270 adults and teenagers with FSGS to see if th…

Matched conditions: FSGS

Phase: PHASE2, PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 06, 2026 15:38 UTC

FSGS

Get alerted when new FSGS trials appear

New drug trial aims to protect kidneys from scarring disease